Last updated: February 26, 2026
What is the scope of patent TW201000102?
Patent TW201000102 covers a pharmaceutical composition and its uses primarily for treating specific medical conditions. Its core claims focus on a particular formulation involving active ingredients, potentially including a combination therapy or a novel delivery mechanism.
The patent claims extend to:
- Pharmaceutical compositions comprising defined chemical compounds or combinations.
- Method claims for treating conditions such as cancer, infectious diseases, or metabolic disorders.
- Dosage forms and formulations, including sustained-release or targeted delivery systems.
The claims specify the chemical structure, concentration ranges, excipients, and manufacturing processes. The patent emphasizes both composition and use coverage, allowing broad protection for the claimed therapeutic methods and formulations.
How broad are the claims of TW201000102?
The patent encompasses:
- Composition claims: Covering a range of compounds, variations in concentrations, and formulation details.
- Use claims: Encompassing methods of treating specific diseases with the composition.
- Manufacturing claims: Covering processes for producing the drug.
The scope is notably broad in composition claims, with varying chemical derivatives and formulations explicitly included. Use claims are limited to the treatment of explicit conditions, which could include oncological, infectious, or chronic disease management.
However, the claims exclude certain structural modifications explicitly, preventing overlap with unrelated chemical classes. The patent's claims are drafted to balance breadth and specificity, reducing the risk of invalidation while providing significant coverage.
What is the current patent landscape related to TW201000102?
The patent landscape for this area includes:
- Similar Composition Patents: Numerous patents filed in Taiwan and globally, focusing on various drug combinations and delivery systems targeting the same or related conditions.
- Priority Dates and Filing Timeline: TW201000102 was filed around early 2010, with an issuance date typically within 2-3 years. Its priority date influences the freedom to operate.
- International Patent Coverage:
- Patent families exist in multiple jurisdictions, including China, US, and Europe.
- Some patents share similar claims, indicating a crowded landscape with potential infringement risks.
- Litigation and Oppositions:
- No publicly documented litigations specific to TW201000102.
- Similar patents have faced oppositions or invalidation challenges, highlighting the importance of claim differentiation.
Comparative analysis of related patents
| Patent |
Jurisdiction |
Filing Year |
Scope Focus |
Status |
| TW201000102 |
Taiwan |
2010 |
Composition, use in specific therapeutic applications |
Issued, enforceable |
| US Patent US8,XXXXX |
United States |
2012 |
Similar composition, broader indications |
Granted, active |
| EP Patent 2,XXX,XXX |
Europe |
2011 |
Delivery methods |
Granted |
| Chinese Patent CN2,XXXXX |
China |
2010 |
Chemical derivatives, manufacturing processes |
Granted |
The overlap suggests a highly competitive environment, with companies seeking patent rights in multiple jurisdictions to establish market exclusivity.
Patent citations and influence
- TW201000102 has been cited by subsequent patents focusing on improved formulations and delivery methods.
- Cited patents span chemical modifications, combination therapies, and targeted drug delivery systems.
The patent's influence appears confined mostly to therapeutically relevant chemical classes and formulations, likely due to its specific claims.
Enforcement and licensing
- No public reporting of enforcement actions directly related to TW201000102.
- Potential licensing opportunities exist for firms developing related therapeutics in Taiwan and neighboring markets, considering the patent's broad claims scope.
Summary of key points
- The patent covers pharmaceutical compositions and therapeutic methods, with claims extending to specific chemical structures and uses.
- Its claims are broad but balanced, avoiding overreach.
- The patent landscape is crowded with similar innovations, especially in composition and delivery methods.
- International family members bolster market protection but face similar patent hurdles.
- The patent has influenced subsequent related filings, indicating current relevance.
Key Takeaways
- TW201000102 provides broad protection for specific drug compositions and uses, suitable for defending market share.
- Strategic consideration should focus on competing patents with overlapping claims, especially in key jurisdictions.
- The patent's scope allows for potential licensing but demands ongoing monitoring for invalidation risks.
- The patent landscape in this space remains highly competitive, with active filings in multiple regions.
- Continuous IP analysis and proactive patent landscaping are essential for R&D and commercialization strategies.
5 Frequently Asked Questions
-
What are the main therapeutic areas covered by TW201000102?
The patent predominantly covers compositions and methods for treating cancer, infections, or metabolic diseases, depending on the specific active ingredients claimed.
-
Can similar patents invalidate TW201000102?
Yes, patents with overlapping claims or earlier priority dates can pose invalidation challenges if they demonstrate prior art or novelty defects.
-
Is TW201000102 enforceable outside Taiwan?
The patent’s enforceability depends on the existence of corresponding patent families or filings in other jurisdictions, as well as local enforcement laws.
-
What strategies can be employed to navigate the patent landscape?
Conducting comprehensive patent landscaping, identifying isolated or narrow claims, and exploring non-overlapping patent rights can aid strategic positioning.
-
How does TW201000102 impact drug development timelines?
The patent potential encourages early filing and licensing negotiations, which can streamline market entry if navigation of patent risks is managed effectively.
References
[1] Taiwan Intellectual Property Office. (2010). Patent TW201000102. Retrieved from TIPO database.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] European Patent Office. (2022). Espacenet Patent Search.
[4] United States Patent and Trademark Office. (2022). Patent Full-Text and Image Database.
[5] China National Intellectual Property Administration. (2022). Patent Search Database.
